ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin

Scandinavian Audiology

Volumn 28, Issue 3, 1999, Pages 139-143

  De Lauretis, Albertina ^a   De Capua, Bruno ^a   Barbieri, Maria Teresa ^a   Bellussi, Luisa ^a   Passàli, Desiderio ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Auditory brainstem; Carboplatin; Cisplatin; Ototoxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; AUDIOMETRY; BLADDER CANCER; CHEMOTHERAPY; CLINICAL ARTICLE; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OTOTOXICITY; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CARBOPLATIN; CISPLATIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING DISORDERS; HUMANS; MALE; MIDDLE AGED; RANDOM ALLOCATION; URINARY BLADDER NEOPLASMS;

EID: 0032814891     PISSN: 01050397     EISSN: None     Source Type: Journal    
DOI: 10.1080/010503999424707     Document Type: Article

References (23)

1. Aguilar-Markulis NV, Beckley S, Priore R, Mettlin C. Auditory toxicity effects of long-term cis-dichlorodiammine platinum II therapy in genito urinary cancer patients J Surg Oncol 1981;16:111-23.
2. Castello MA, Clerico A, Deb G, Dominici C, Fidani P, Donfrancesco A. High dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 1990;12:297-300.
3. Coupland SG, Ponton CW, Eggermont JJ, Bowen TJ, Grant RM. Assessment of cisplatin-induced ototoxicity using derived-band ABRs. Int J Pediatr Otorhinolaryngol 1991;22:237-48.
4. Delb W, Feilen S, Koch A, Federspil P. Experimental investigations on the ototoxicity of cisplatin and carboplatin. Laryngo-Rhino-Otol 1993;72/1:24-7.
5. Fausti SA, Frey HR, Henry JA, Olson DJ, Schaffer HI. Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses. J Am Acad Audiol 1992;3:397-404.
6. Gratton MA. The interaction of cisplatin and noise on the peripheral auditory system. Hear Res 1990;50:211-224.
7. Helson L, Okonkwo E, Anton L, Cvitkovic E. Cis-platinum ototoxicity. Clin Toxicol 1978;13:469-79.
8. Jerger J. Diagnostic use of impedance measures. In: Handbook of clinical impedance audiometry. Dobbs Ferry, N.Y.: Morgan Press, 1975;149-74.
9. Jewett DL, Williston JS. Auditory evoked far fields averaged from the scalp of humans. Brain 1971;94: 681-96.
10. Kennedy IC, Fitzharris BM, Colls BM, Atkinson CH. Carboplatin is ototoxic Cancer Chemother Pharmacol 1990;26:232-4.
11. Kingston JE, Abramovich S, Billings RJ, Malpas JS, Fuller AP. Assessment of the effect of chemotherapy and radiotherapy on the auditory function of children with cancer. Clin Otolaryngol 1986;11:403-9.
12. Lau SK, Wei WI, Sham JS, Choy DTK, Hui Y. Early changes of auditory brain stem evoked response after radiotherapy for nasopharyngeal carcinoma. A prospective study. J Laryngol Otol 1992;106:887-92.
13. Laurell G, Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope 1990;100:724-34.
14. Maiese K, Walker RW, Gargan R, Victor JD. Intra-arterial cisplatin-associated optic and otic toxicity. Arch Neurol 1992;49:83-6.
15. Metz O. The acoustic impedance measured on normal and pathological ears. Acta Otolaryngol (Stockh) 1946; (Suppl 63):397-405.
16. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
17. Reddel RR, Kefford RF, Grant JM, Coates AS, Fox RM, Tattersal HN. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep 1982;66:19-23.
18. Rybak LP. Cisplatinum associated hearing loss. J Laryngol Otol 1981;95:745-7.
19. Schweitzer VG. Cisplatin-induced ototoxicity: effect of pigmentation and inhibitory agents Laryngoscope 1993; 103 (Suppl 59):1-52.
20. van der Hulst RJAM, Dreschler WA, Urbanus NAM. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives. Ann Otol Rhinol Laryngol 1988;97:133-7.
21. Vermorken JB, Kapteijn TS, Hart AAM, Pinedo HM. Ototoxicity of cis-diammine dichloroplatinum (II). Influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 1983;19:53-8.
22. Weatherly RA, Owen JJ, Catlin FI, Mahoney DH. Cisplatinum ototoxicity in children. Laryngoscope 1991; 101:917-24.
23. Wright CG, Schaefer SD. Inner ear histopathology in patients treated with cis-platinum. Laryngoscope 1982; 92:1408-13.